SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 83 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2014. The put-call ratio across all filers is 2.83 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $158,000 | -13.7% | 70,814 | +16.3% | 0.00% | 0.0% |
| Q3 2014 | $183,000 | -16.8% | 60,882 | +13.0% | 0.00% | -50.0% |
| Q2 2014 | $220,000 | +56.0% | 53,878 | +64.9% | 0.00% | +100.0% |
| Q1 2014 | $141,000 | -17.5% | 32,668 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $171,000 | -17.0% | 32,668 | 0.0% | 0.00% | -50.0% |
| Q3 2013 | $206,000 | +26.4% | 32,668 | 0.0% | 0.00% | +100.0% |
| Q2 2013 | $163,000 | – | 32,668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|